CD8A and hepatocellular carcinoma: Tregs cells, one of the important constituents of the HCC tumour microenvironment, cognate with a reduction in density and functioning of CD8+ T-cells, hence a therapeutic measure targeting Tregs would not only help in establishing of antitumour immune responses but can also improve survival [56,57].